What is the equity of Vita 34 this year?
Vita 34 has equity of 16.5 M EUR this year.
Vita 34 Equity 2024
Vita 34 Equity
16.5 M EUR
Vita 34 Dividend yield
3.11 %
Ticker
V3V.DE
ISIN
DE000A0BL849
WKN
A0BL84
In 2024, Vita 34's equity was 16.5 M EUR, a -61.7% increase from the 43.07 M EUR equity in the previous year.
Vita 34 Aktienanalyse
What does Vita 34 do?
Vita 34 AG is a leading company in the field of stem cell technology. It was founded in Leipzig in 1997 and has since had an impressive history. The company focuses on the storage of stem cells from umbilical cord blood and umbilical cord tissue. These stem cells can be used later in life for the treatment of various diseases. The business model of Vita 34 AG involves customers storing and preserving their stem cells with them. The company offers various options to meet individual needs. Customers can choose between different packages that include different services. For example, a package can be booked that only includes the storage of umbilical cord blood, or another package that also includes the storage of umbilical cord tissue. In addition to stem cell storage, Vita 34 AG also offers various supplementary services. For example, customers can have genetic predisposition tests conducted to determine the risk for certain diseases. This allows customers to take targeted preventive measures and consider alternative treatment options if necessary. Another important aspect of Vita 34 AG's business is the trade of stem cells. By storing umbilical cord blood and tissue, the company builds an extensive portfolio of stem cells that can be sold to medical institutions when needed. The company works closely with doctors and research institutions to use the stem cells efficiently. Vita 34 AG operates not only in German-speaking countries but also has branches in other countries such as Austria, Switzerland, and the Netherlands. This allows the company to operate internationally and cater to the specific needs of individual countries. In addition to the mentioned services, Vita 34 AG also offers various products. For example, there are special storage kits for the storage of umbilical cord blood and tissue. Test kits for genetic predisposition tests can also be purchased. Vita 34 AG aims to increase awareness of stem cells and their therapeutic possibilities. Through intensive marketing, including in social networks, the company strives to ensure that as many people as possible learn about the benefits of stem cell technology and decide to store their stem cells with the company. Vita 34 AG has had an impressive development in recent years. It is now globally known and has established itself as a competent and reliable partner in the field of stem cell technology. With its wide range of services and products, it is often the first choice for many people when it comes to storing stem cells. Vita 34 ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Vita 34's Equity
Vita 34's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vita 34's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Vita 34's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Vita 34's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Vita 34’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Vita 34 Stock
What was the equity of Vita 34 compared to the previous year?
The equity of Vita 34 has increased/decreased by -61.7% decreased compared to the previous year.
What impact does a high equity have on investors of Vita 34?
A high equity is advantageous for investors of Vita 34 as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Vita 34?
A low equity can be a risk for investors of Vita 34, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Vita 34 affect the company?
An increase in equity of Vita 34 can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Vita 34 affect the company?
A reduction in equity of Vita 34 can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Vita 34?
Some factors that can affect the equity of Vita 34 include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Vita 34 so important for investors?
The equity of Vita 34 is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Vita 34 take to change the equity?
To change equity, Vita 34 can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Vita 34 pay?
Over the past 12 months, Vita 34 paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 3.11 %. For the coming 12 months, Vita 34 is expected to pay a dividend of 0 EUR.
What is the dividend yield of Vita 34?
The current dividend yield of Vita 34 is 3.11 %.
When does Vita 34 pay dividends?
Vita 34 pays a quarterly dividend. This is distributed in the months of September, July, June, July.
How secure is the dividend of Vita 34?
Vita 34 paid dividends every year for the past 0 years.
What is the dividend of Vita 34?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Vita 34 located?
Vita 34 is assigned to the 'Health' sector.
Wann musste ich die Aktien von Vita 34 kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Vita 34 from 6/7/2019 amounting to 0.16 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2019.
When did Vita 34 pay the last dividend?
The last dividend was paid out on 6/7/2019.
What was the dividend of Vita 34 in the year 2023?
In the year 2023, Vita 34 distributed 0 EUR as dividends.
In which currency does Vita 34 pay out the dividend?
The dividends of Vita 34 are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Vita 34 stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Vita 34
Our stock analysis for Vita 34 Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vita 34 Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
